(Q53881405)

English

Comparison of Three 7-Day Pantoprazole-Based Helicobacter pylori Eradication Regimens in a Mexican Population with High Metronidazole Resistance.

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

Comparison of Three 7-Day Pantoprazole-Based Helicobacter pylori Eradication Regimens in a Mexican Population with High Metronidazole Resistance. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

Helicobacter pylori

0 references

1 reference

based on heuristic

inferred from title

author name string

M Dehesa

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

J Larisch

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

M Dibildox

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

M Di Silvio

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

L H Lopez

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

E Ramirez-Barba

6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

J Torres

7

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

22

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

75-85

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How to treat Helicobacter pylori infection--should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pantoprazole: a new proton pump inhibitor in the management of upper gastrointestinal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: nitroimidazole resistance in Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Comparison of 2 schedules based on pantoprazole for eradication of Helicobacter pylori in patients with active duodenal ulcer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Where are We with current therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic resistance mechanisms of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of Helicobacter pylori infection in the management of peptic ulcer disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metronidazole resistance in Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Challenges to therapy in the future

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: Helicobacter pylori: where are we and where are we going?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: the control of gastric acid and Helicobacter pylori eradication.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decision-making in dyspepsia: controversies in primary and secondary care

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modified short-term triple therapy--ranitidine, clarithromycin, and metronidazole--for cure of Helicobacter pylori infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The ideal therapy must be defined in each geographical area: experience with a quadruple therapy in Spain

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of Helicobacter pylori: current status and issues

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Mexican consensus on Helicobacter pylori. National Consensus Group of the Mexican Association of Gastroenterology]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23315395

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200222020-00002

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/23315395

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53881405&oldid=1582791154"